ISC — COVID-19 — High Performance Low Cost Detection of Biomarkers ### 📋 Eligible Entities - Canadian corporations (small, medium, and large enterprises) - Canadian academic institutions and research organizations - Non-profit organizations registered in Canada - Consortium partnerships (multiple eligible entities collaborating) - Indigenous-owned businesses and organizations - Start-ups and spin-offs with Canadian registration - Must have the capacity to develop and test biomarker detection innovations - Must demonstrate commitment to commercialization or real-world deployment ### 💰 Funding Details - Maximum Grant Amount: $300,000 CAD per Phase 1 project - Project Duration: Up to 6 months for Phase 1 - Repayability: Non-repayable grant (contribution-based funding) - Matching Requirements: Check with program administrator for cost-share obligations (typically 20-50% applicant contribution expected) - Funding Release: Installment-based upon milestone completion and reporting - No Interest or Royalties: Grant does not accrue interest; no intellectual property royalties owed to funder ### 🛠️ Approved Expenses - Research and development payroll (scientists, technicians, project managers) - Laboratory equipment and instrumentation purchases - Materials, reagents, and consumables for prototype development - Testing and validation of biomarker detection systems - User interface and software development - Clinical or field trial preparation and pilot testing - Regulatory pathway assessment and documentation - Consulting fees (specialized expertise in biomarkers, diagnostics, or commercialization) - Travel for research collaboration and knowledge transfer - Technical writing and intellectual property filing support ### ⚠️ Conditions & Milestones - Deadline: Specific application deadline set by Innovation, Science and Economic Development Canada (ISED) - Phase 1 Milestones: - Proof-of-concept demonstration of biomarker detection capability - Performance validation against reference standards - User accessibility assessment in relevant settings - Preliminary cost analysis and scalability plan - Final Phase 1 report with technical